Glaxo SmithKline announces start of Phase lll programme for mepolizumab in severe refractory asthma. 160;is a chronic condition that ultimately results in the inflammation of the air passages, making it extremely difficult to breath. Asthma can be life threatening, especially when serious cases are not effectively managed by use of an inhaler or medication. Tuesday, October 30, 2012. Tuesday, October 30, 2012.

Glaxo SmithKline announces start of Phase lll programme for mepolizumab in severe refractory asthma. On October 30, 2012. Is a chronic condition that ultimately results in the inflammation of the air passages, making it extremely difficult to breath. Asthma can be life threatening, especially when serious cases are not effectively managed by use of an inhaler or medication. Biocon features as the only Asian Company in the Global Top 20 BioPharma Employers. On October 30, 2012.

Success is just a step away! Bringing you closer to the bioworld! That may put an end to cutting healthy cells during tumour removal. Monkey donor gets human head transplant. Is now in Maharashtra! CSIR NET Countdown Timer. This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Attention CSIR Aspirants CSIR Fellowship has been revised.